Treatment-Resistant Depression Affected 34% in Pakistan DIVERGE Study
TL;DR: A 2026 preprint in medRxiv found that treatment-resistant depression affected 34% of medication-exposed major-depression patients in Pakistan’s DIVERGE study, with social support and CYP2C19 metabolizer status standing out as locally important treatment-response markers. Key Findings 3,677 eligible patients: The treatment-resistance analysis included adults with major depressive disorder who had medication exposure and enough adherence …
